Seidl et al. 70M Metastatic Lung Carcinoma

by Benny | Apr 27, 2021

MultiHance® 9 Image Library 9 Seidl et al. 70M Metastatic Lung Carcinoma MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.70-year-old man with metastatic lung carcinoma These are representative images...

Seidl et al. 58F Metastatic Melanoma

by Benny | Apr 27, 2021

MultiHance® 9 Image Library 9 Seidl et al. 58F Metastatic Melanoma MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.58-year-old woman with metastatic melanoma These are representative images from...

Rowley et al. 55F Glioblastoma with Recurrent Disease

by Benny | Apr 27, 2021

MultiHance® 9 Image Library 9 Rowley et al. 55F Glioblastoma with Recurrent Disease MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Omniscan™ (gadodiamide)1 The ENHANCE Study Rowley et al. 55-year-old...

Maravilla et al. 51F Metastatic Lung Cancer

by Benny | Apr 27, 2021

MultiHance® 9 Image Library 9 Maravilla et al. 51F Metastatic Lung Cancer MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Magnevist® (gadopentetate dimeglumine)1 Maravilla et al.51-year-old woman with...

Colosimo et al. 72F Primary Cerebral Lymphoma

by Benny | Apr 21, 2021

MultiHance® 9 Image Library 9 Colosimo et al. 72F Primary Cerebral Lymphoma MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 Colosimo et al.72-year-old woman with primary...